Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | f the Exchange Act. ☐ Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Ap |
Stammdaten
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Unternehmen & Branche
| Name | Tilray Brands, Inc. |
|---|---|
| Ticker | TLRY |
| CIK | 0001731348 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2833 · Medicinal Chemicals & Botanical Products |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 784,0 Mio. USD |
| Beta | 2,11 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-02-28 | 10-Q | 206,732,000 | -26,572,000 | -0.24 | 2,074,722,000 | 1,557,368,000 |
| 2025-11-30 | 10-Q | 217,507,000 | -44,931,000 | -0.41 | 2,098,599,000 | 1,579,827,000 |
| 2025-08-31 | 10-Q | 209,501,000 | -322,000 | 0.00 | 2,082,646,000 | 1,540,743,000 |
| 2025-05-31 | 10-K | 821,309,000 | -2,186,738,000 | -2.46 | 2,074,327,000 | 1,511,474,000 |
| 2025-02-28 | 10-Q | 185,780,000 | -789,436,000 | -8.69 | ||
| 2024-11-30 | 10-Q | 210,950,000 | -85,342,000 | -0.99 | 4,191,754,000 | 3,472,928,000 |
| 2024-08-31 | 10-Q | 200,044,000 | -39,165,000 | -0.04 | 4,261,867,000 | 3,478,091,000 |
| 2024-05-31 | 10-K | 788,942,000 | -244,981,000 | -0.33 | 4,221,665,000 | 3,442,906,000 |
| 2024-02-29 | 10-Q | 188,340,000 | -92,701,000 | -0.12 | 4,212,856,000 | 3,358,858,000 |
| 2023-11-30 | 10-Q | 193,771,000 | -49,008,000 | -0.07 | 4,330,557,000 | 3,368,337,000 |
| 2023-08-31 | 10-Q | 176,949,000 | -71,525,000 | -0.10 | 4,402,250,000 | 3,379,374,000 |
| 2023-05-31 | 10-K | 627,124,000 | -1,452,656,000 | -2.35 | 4,307,259,000 | 3,315,692,000 |
| 2023-02-28 | 10-Q | 145,589,000 | -1,170,998,000 | -1.90 | 4,375,900,000 | 3,403,662,000 |
| 2022-11-30 | 10-Q | 144,136,000 | -69,463,000 | -0.11 | 5,474,379,000 | 4,470,276,000 |
| 2022-08-31 | 10-Q | 153,211,000 | -73,482,000 | -0.13 | 5,592,482,000 | 4,525,343,000 |
| 2022-05-31 | 10-K | 628,372,000 | -476,801,000 | -0.99 | 5,449,694,000 | 4,398,805,000 |
| 2022-02-28 | 10-Q | 151,871,000 | 43,190,000 | 0.09 | 5,819,436,000 | 4,627,240,000 |
| 2021-11-30 | 10-Q | 155,153,000 | -201,000 | 0.00 | 5,763,486,000 | 4,436,288,000 |
| 2021-08-31 | 10-Q | 168,023,000 | -41,649,000 | -0.08 | 5,986,352,000 | 4,319,473,000 |
| 2021-05-31 | 10-K | 513,085,000 | 47,204,000 | 0.18 | 6,025,362,000 | 4,459,070,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Hopkinson David G. | Director | Open Market Sale | -33,556 | 6.94 | -232,878.64 | -261,4% | |
| 2025-07-31 | Gendel Mitchell | Officer, Global General Counsel | Open Market Purchase | 6,000 | 0.58 | 3,496.20 | +3,9% | |
| 2025-07-30 | Merton Carl A | Officer, Chief Financial Officer | Open Market Purchase | 33,500 | 0.60 | 19,939.20 | +22,4% | |
| 2025-07-30 | SIMON IRWIN D | Officer, President and CEO | Open Market Purchase | 165,000 | 0.61 | 100,105.50 | +112,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.